The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $19.83

Today's change+0.13 +0.66%
Updated November 24 1:00 PM EST. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $19.83

Today's change+0.13 +0.66%
Updated November 24 1:00 PM EST. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc up (U.S.)$0.13

Spectrum Pharmaceuticals Inc closed up Friday by (U.S.)$0.13 or 0.66% to (U.S.)$19.83. Over the last five days, shares have gained 1.69% and 347.63% year to date. Shares have outperformed the S&P 500 by 334.70% during the last year.

Key company metrics

  • Open(U.S.) $19.79
  • Previous close(U.S.) $19.70
  • High(U.S.) $19.98
  • Low(U.S.) $19.50
  • Bid / Ask(U.S.) $18.40 / (U.S.) $20.00
  • YTD % change+347.63%
  • Volume298,234
  • Average volume (10-day)1,234,333
  • Average volume (1-month)2,159,242
  • Average volume (3-month)1,595,601
  • 52-week range(U.S.) $3.85 to (U.S.) $21.95
  • Beta1.66
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.00
Updated November 24 1:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.21%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue36342935
Total other revenue--------
Total revenue36342935
Gross profit24211924
Total cost of revenue12131011
Total operating expense52535053
Selling / general / administrative19171918
Research & development14151516
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-15-18-21-17
Interest income (expense), net non-operating-2-2-2--
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-20-23-19
Income after tax-19-20-23-17
Income tax, total-100-2
Net income-19-20-23-17
Total adjustments to net income--------
Net income before extra. items-19-20-23-17
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-19-20-23-17
Inc. avail. to common incl. extra. items-19-20-23-17
Diluted net income-19-20-23-17
Dilution adjustment--------
Diluted weighted average shares83797980
Diluted EPS excluding extraordinary itemsvalue per share-0.22-0.26-0.29-0.22
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.22-0.26-0.29-0.22